Search results for N-terminal

Anti-IL-17RA antibody - N-terminal, Abcam, AB180904

What is this antibody validated in? Anti-IL-17RA antibody - N-terminal (ab180904) is a rabbit polyclonal antibody and is validated for use in Western Blot (WB), Immunohistochemistry (IHC-P) in Human, Mouse samples. What is the molecular weight of IL-17RA? Anti-IL-17RA - N-terminal (ab180904) specifically detects a band for IL-17RA (UniProt: Q96F46) at a molecular weight of 96kDa. Trusted by the scientific community Anti-IL-17RA - N-terminal (ab180904) was first used in a scientific publication in 2013 and has been cited over 10 times in peer-reviewed journals.

Anti-Cyclin D2 antibody - N-terminal, Abcam, AB226972

Anti-CYLD antibody [733] - N-terminal, Abcam, AB200476

Anti-K31 antibody [EPR12849] - N-terminal, Abcam, AB181081

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-P cadherin antibody - N-terminal, Abcam, AB190076

Anti-P Glycoprotein antibody - N-terminal, Abcam, AB202976

Anti-PADI3 / PAD3 antibody - N-terminal, Abcam, AB183209

Anti-PAR6 antibody [EPR12378] - N-terminal, Abcam, AB180159

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-SEC24D antibody [EPR16089] - N-terminal, Abcam, AB191566

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-Semaphorin 3A antibody - N-terminal, Abcam, AB226793